Medpace insider exercises 3,000 stock options
Medpace’s Executive VP of Operations exercised 3,000 stock options into common shares, raising her direct common stock holdings to 65,984 shares.
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) executive Susan E. Burwig, Executive Vice President of Operations, exercised employee stock options for 3,000 shares of common stock on September 15, 2026 at an exercise price of $166.73 per share. The option, which vested in full on October 27, 2025 and expires on October 27, 2026, was converted into common stock, increasing her directly held common shares to 65,984. Following this transaction she continues to hold 8,028 stock options directly, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
3,000 shares exercised/converted
Exercise
2 txns
Insider
BURWIG SUSAN E
Role
Exec. VP, Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F1 | 3,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,000 | $166.73 | $500K |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 8,028 contracts (Direct);
Common Stock — 65,984 shares (Direct)
Footnotes (1)
- F1. The option vested in full on October 27, 2025.
Key Figures
Options exercised: 3,000 options
Exercise price: $166.73 per share
Common shares after transaction: 65,984 shares
+4 more
7 metrics
Options exercised
3,000 options
Employee stock options converted into common stock on September 15, 2026
Exercise price
$166.73 per share
Exercise price for 3,000 employee stock options
Common shares after transaction
65,984 shares
Direct Medpace common stock holdings by Susan E. Burwig after the exercise
Options remaining after transaction
8,028 options
Directly held employee stock options remaining after the reported exercise
Underlying shares exercised
3,000 shares
Common shares issued upon option exercise on September 15, 2026
Option vesting date
October 27, 2025
Date the exercised option vested in full
Option expiration date
October 27, 2026
Expiration date for the exercised option grant
Key Terms
Employee Stock Option (Right to Buy), Common Stock, vested in full, expiration date
4 terms
Employee Stock Option (Right to Buy) financial
"Employee Stock Option (Right to Buy)"
Common Stock financial
"Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vested in full financial
"The option vested in full on October 27, 2025."
expiration date financial
"expiration date: 2026-10-27"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace Holdings (MEDP) report for Susan E. Burwig?
Susan E. Burwig exercised 3,000 stock options for Medpace common stock on September 15, 2026, converting them into 3,000 shares of common stock at an exercise price of $166.73 per share.
What was the exercise price of the Medpace (MEDP) options exercised by Susan E. Burwig?
The employee stock options exercised by Susan E. Burwig on September 15, 2026 had an exercise price of $166.73 per share for 3,000 underlying shares of Medpace common stock.
Does the Medpace (MEDP) Form 4 indicate a Rule 10b5-1 trading plan for this transaction?
No. The filing indicates that no Rule 10b5-1 trading plan applies to the transactions reported for Susan E. Burwig on September 15, 2026.
What Medpace (MEDP) stock option position does Susan E. Burwig retain after this transaction?
Following the option exercise reported on September 15, 2026, Susan E. Burwig continues to hold 8,028 employee stock options directly, as stated in the filing’s post-transaction holdings.
When did the Medpace (MEDP) options exercised by Susan E. Burwig vest and when do they expire?
The employee stock option exercised for 3,000 shares vested in full on October 27, 2025 and carries an expiration date of October 27, 2026, as disclosed in the footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
